Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has lifted the ...

Vanda ( ($VNDA) ) has shared an update. On December 4, 2025, Vanda Pharmaceuticals announced that the FDA has lifted the partial clinical hold on ...

Investing.com -- Vanda Pharmaceuticals (NASDAQ:VNDA) stock rose 11% in after-hours trading on Thursday after the company announced that the U.S. Food and Drug Administration (FDA) has lifted a partial ...

Vanda Pharmaceuticals said the Food and Drug Administration has lifted the partial clinical hold on its motion sickness drug tradipitant . The decision allows the Washington, D.C., company to extend ...

Tradipitant could become the first new pharmacologic treatment for motion sickness in over 40 years.

With thousands of press releases published each month, it can be difficult to keep up with everything on PR Newswire. To help ...

UK group Cycle Pharma has made an unsolicited takeover bid to buy Vanda Pharma of the US, which is already fending off an overture from Future Pak. The $8-per-share offer values Nasdaq-listed Vanda at ...

A new exhibition at the V&A explores how better use can be made of British hardwood in construction. dRMM: Building from ...

Voiso, a global provider of AI-powered contact center software, has published new insights on how businesses can transform speech analytics data into measurable improvements in customer experience (CX ...

Vanda Pharmaceuticals (VNDA) announced that the FDA has lifted the partial clinical hold on protocol VP-VLY-686-3403, which until today limited ...

Oil prices firmed on Thursday after Ukrainian attacks on Russia's oil infrastructure signalled potential supply constraints, ...

Oil prices gained on Thursday after Ukrainian attacks on Russia's oil infrastructure signalled potential supply constraints, ...